Special Edition Bighearted Warriors Unite – Understanding Camzyos (Mavacamtin)

Jul 18, 2022 2:00PM—3:30PM


With the recent approval of Camzyos (Mavacamtin) by the FDA, this Webinar will address questions and concerns that our community members may have. Presented by the HCMA, in partnership with PACH, and members of the Camzyos team at Bristol Myers Squibb (BMS), Topics will include: Label indication, Patient Assistant Programs, Medicare Access and more.

Cost 0.0